To investigate the inhibitory effects of a GSK-3β inhibitor on cancer cell proliferation, cell proliferation was determined after long-term (120 h) treatment with AR-A014418, a specific GSK-3β inhibitor17 (Fig. 1a). The gene discussed is GSK3B; the disease is cancer.